| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.067 | 0.7 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |